FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.
Alzheimer's
Recent gaffes by Biden and Trump may be signs of normal aging — or may be nothing
President Biden and former President Trump have both experienced public memory lapses. But brain experts say such slips, on their own, are not a cause for concern.
Blood tests can help diagnose Alzheimer's — if they're accurate enough. Not all are
A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
Facing dementia without a diagnosis is crushing. A new program in Kenya offers help
In Kenya, someone with symptoms of dementia may not be able to get a diagnosis — leaving both patient and family with no idea of what is going on. A program in Kenya is trying to change that.
Scientists built the largest-ever map of the human brain. Here's what they found
A new atlas of the human brain could help explain abilities like language – and vulnerabilities, like Alzheimer's disease.
When a brain injury impairs memory, a pulse of electricity may help
A severe traumatic brain injury can make it hard to remember recent events or conversations. But a form of brain stimulation appears to ease this memory deficit.
When illness or death leave craft projects unfinished, these strangers step in to help
It can be heartbreaking to let go of a hand-made rug or sweater that a loved one didn't quite finish. A group of volunteer knitters, quilters and other crafters offer some closure.
An experimental Alzheimer's drug outperforms one just approved by the FDA
In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.
Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow
The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.
Huntington's spreads like 'fire in the brain.' Scientists say they've found the spark
Diseases like Alzheimer's and Parkinson's spread through the brain like a forest fire. A new study suggests how the fire starts.